Research compound
Retatrutide
10mg vial
Retatrutide is a synthetic triple-agonist molecule targeting GLP-1, GIP, and glucagon receptors. Supplied as a lyophilised powder for in-vitro laboratory research.
In stockShips in 1-3 business daysDiscreet packaging
$130.00 AUD
Bulk pricing
1 unit$130.00 each
3+ units$117.00 each · save 10%
5+ units$110.50 each · save 15%
Specifications
Purity≥99%
FormLyophilised powder
Vial size10mg
TestingHPLC
StorageStore at -20°C, protect from light
ReconstitutionBacteriostatic water
Certificate of Analysis
Independently HPLC-tested. The current batch COA is available for download below. Batch-specific COAs for future purchases are available on request.
Download COA (PDF)For in-vitro research use only. Not for human or animal consumption. Not approved by the TGA. Not intended to diagnose, treat, cure, or prevent any disease.